arrow
Return

Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness

delete2020-07-15
delete29
delete
OA
AI
W
William Bain
李汇华 (Li, HH)
R
Rick van der Geest
S
Sara Moore
T
Tolani F. Olonisakin
B
Brian Ahn
E
Erin Papke
K
Kaveh Moghbeli
R
Rebecca DeSensi
S
Sarah F. Rapport
M
Melissa Saul
M
Mei Hulver
Z
Zeyu Xiong
R
Rama K. Mallampalli
P
Prabir Ray
A
Alison Morris
L
Lina Ma
Y
Yohei Doi
Y
Yingze Zhang
G
Georgios D. Kitsios
H
Hrishikesh S. Kulkarni
B
Bryan J. McVerry
V
Viviana P. Ferreira
M
Mehdi Nouraie
J
Janet Lee *
DOI:10.1164/rccm.201910-2083OCdelete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Rationale: Complement is crucial for host defense but may also drive dysregulated inflammation. There is limited understanding of alternative complement function, which can amplify all complement activity, during critical illness. Objectives: We examined the function and key components of the alternative complement pathway in a series of critically ill patients and in a mouse pneumonia model. Methods: Total classical (CH50) and alternative complement (AH50) function were quantified in serum from 321 prospectively enrolled critically ill patients and compared with clinical outcomes. Alternative pathway (AP) regulatory factors were quantified by ELISA (n = 181) and examined via transcriptomics data from external cohorts. Wild-type, Cfb(-/-), and C3(-/-) mice were infected intratracheally with Klebsiella pneumoniae (KP) and assessed for extrapulmonary dissemination. Measurements and Main Results: AH50 greater than or equal to median, but not CH50 greater than or equal to median, was associated with decreased 30-day mortality (adjusted odds ratio [OR], 0.53 [95% confidence interval (CI), 0.31-0.91]), independent of chronic liver disease. One-year survival was improved in patients with AH50 greater than or equal to median (adjusted hazard ratio = 0.59 [95% CI, 0.41-0.87]). Patients with elevated AH50 had increased levels of AP factors B, H, and properdin, and fewer showed a hyperinflammatory subphenotype (OR, 0.30 [95% CI, 0.18-0.49]). Increased expression of proximal AP genes was associated with improved survival in two external cohorts. AH50 greater than or equal to median was associated with fewer bloodstream infections (OR, 0.67 [95% CI, 0.45-0.98). Conversely, depletion of AP factors, or AH50 less than median, impaired in vitro serum control of KP that was restored by adding healthy serum. Cfb(-/-) mice demonstrated increased extrapulmonary dissemination and serum inflammatory markers after intratracheal KP infection compared with wild type. Conclusions: Elevated AP function is associated with improved survival during critical illness, possibly because of enhanced immune capacity.
Keywords:
complement
serum
host defense
pneumonia
critical illness
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

American Journal of Respiratory and Critical Care Medicine cover
American Journal of Respiratory and Critical Care Medicine
IF:
19.4
Papers:
1.8W
Citations:
6.7W

Organization

University of Wisconsin System cover
University of Wisconsin System
Scholars:
6.7W
Papers: 5.8W
Citations: 382
U
University of Pittsburgh
Scholars:
4.5W
Papers: 3.6W
Citations: 7.1W
P
pennsylvania commonwealth system of higher education (pcshe)
Scholars:
12.9W
Papers: 11.7W
Citations: 177
researcher View more organizations